Halozyme Therapeutics reported $75.59M in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amarin AMRN:US $ -13.07M 21.85M
Amgen AMGN:US $ 2378M 1550M
Aptinyx Inc APTX:US $ -21206000 1.34M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Baxter International BAX:US $ 495M 71M
Cara Therapeutics CARA:US $ -1124000 29.75M
Cytokinetics CYTK:US $ -69.2M 14.4M
Eli Lilly And LLY:US $ 1476M 72.6M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Immunogen IMGN:US $ -34.23M 6.86M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
Intra Cellular Therapies ITCI:US $ -77.32M 8.18M
Intrexon XON:US $ -25.47M 9.8M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Mannkind MNKD:US $ -1.66M 30.74M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Peregrine Pharmaceuticals PPHM:US $ 6.93M 3.84M
Pfizer PFE:US $ 7647M 1733M
Rigel Pharmaceuticals RIGL:US $ -19.78M 6.74M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vanda Pharmaceuticals VNDA:US $ 10.82M 1.55M